Sentence examples for limited viability from inspiring English sources

The increase in m-to-s flux is small, however, it should be noted that the incubations time with AII was limited due to the limited viability of mouse jejunum in Ussing chambers.

A significant limitation has been the limited viability of allogeneic cells used in the majority of tissue engineered skin equivalents and the high cost and limited shelf life associated with using autologous cells.

The use of primary human astrocytes from central nervous system tissue is extremely difficult and is limited by its high sensitivity and limited viability.

Furthermore, hAMSCs cultured in standard conditions have shown limited proliferative and migratory capabilities, as well as limited viability.

Since electron microscopy showed no ORF75c-dependent virion assembly defect, the limited viability of ORF75c− viruses seemed likely to reflect a problem in establishing infection.

First, HDV reaches maximal replication in PHH by 6 days, compared to 12 for HBV; based on our observations of the limited viability of the primary human hepatocytes cultures, HDV was therefore preferable.

However, limited cell viability under hypoxic conditions has restricted MSC differentiation capacity and thus restricted its clinical application.

In contrast, exposure to 1 mm DSP for 15 min led to severely limited cell viability and phenotypic expression probably due to the increased crosslinking time.

Communities address stigmatization, limited economic viability and other common challenges faced by formerly abducted persons – including children and women – and look together for solutions to reduce their vulnerability.

Recently, we overcame the challenge of limited cell viability inherent in dissociation of solid tumors by transplanting equal size, intact fragments (10 mg containing 1 × 105 cells) and monitoring tumor initiation with or without targeted treatment to successfully detect inhibition of tumor initiation with treatment.

However, the effectiveness of the HTS technology is usually compromised by hits that fail in later stages of drug development, especially in time consuming and costly clinical trials, due to unsatisfactory pharmacokinetic properties, poor pharmacodynamic profiles, limited cell viability, possible toxicity, etc.